Havas ECS launches cannabinoid med ed program
The program will launch at a November conference in New York.
News
Five things for pharma marketers to know: Friday, September 13, 2019
Twenty states reject Purdue settlement proposal; Teen vaping continues to rise; GE Healthcare wins approval for AI-powered X-ray.
The Escalator: Top people moves at Imvax, Bayer and Ogilvy Health
Plus: Precision names CEO as it rebrands.
Cambridge BioMarketing names Ben Beckley president
Beckley joined the agency from parent company Ashfield.
Five things for pharma marketers to know: Thursday, September 12, 2019
Purdue close to opioid suit settlement; PillPack loses access to patient history data; White House considers flavored vape ban.
What an 11-figure settlement could mean for Purdue Pharma
The lawsuits are set to go to trial next month.
Trump administration mulls ban on flavored e-cigarettes
President Trump met with top federal health officials to discuss a response to the teen vaping epidemic.
Juul’s new marketing strategy doesn’t hold up to FDA scrutiny
The FDA sent its first warning letter to Juul after months of efforts to crack down on the company’s marketing tactics.
Five things for pharma marketers to know: Wednesday, September 11, 2019
Sixth person dies from vaping mystery illness; Pelosi drug pricing bill goes public; Apple launches Apple Watch health studies.
Movember aims to end mental health stigmas among men
Ad Council Edge, the organization’s new strategic consultancy, helped produce the initiative.
Want to read more?
Please login or register first to view this content.
